Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-28
2008-09-09
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S339000, C546S199000
Reexamination Certificate
active
07423054
ABSTRACT:
The present invention provides for compounds of Formula I:wherein R2, R3, R4, R5, R6, R7, X, and L have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of central nervous disorders and conditions including attention deficit hyperactivity disorder, neuropathic pain, urinary incontinence, anxiety, depression, and schizophrenia and fibromyalgia. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I.
REFERENCES:
patent: 3428634 (1969-02-01), Palazzo
patent: 3488353 (1970-01-01), Archer
patent: 3678059 (1972-07-01), Gschwend et al.
patent: 3681382 (1972-08-01), Gschwend
patent: 3712903 (1973-01-01), Ambrus
patent: 3781439 (1973-12-01), Zoni
patent: 4474964 (1984-10-01), Ibuki et al.
patent: 4549023 (1985-10-01), Ibuki et al.
patent: 4585869 (1986-04-01), Ibuki et al.
patent: 4670447 (1987-06-01), Strupczewski
patent: 4710573 (1987-12-01), Strupczewski
patent: 4758668 (1988-07-01), Strupczewski
patent: 4775761 (1988-10-01), Strupczewski
patent: 4806649 (1989-02-01), Strupczewski
patent: 4853470 (1989-08-01), Strupczewski
patent: 4933460 (1990-06-01), Strupczewski
patent: 4954503 (1990-09-01), Strupczewski et al.
patent: 4957916 (1990-09-01), Kennis et al.
patent: 4999356 (1991-03-01), Strupczewski et al.
patent: 5015740 (1991-05-01), Kennis et al.
patent: 5077405 (1991-12-01), Strupczewski et al.
patent: 5134236 (1992-07-01), Strupczewski et al.
patent: 5348968 (1994-09-01), Lavielle et al.
patent: 5494908 (1996-02-01), O'Malley et al.
patent: 5538984 (1996-07-01), Villalobos et al.
patent: 5580982 (1996-12-01), O'Malley et al.
patent: 5681954 (1997-10-01), Yamamoto et al.
patent: 5750542 (1998-05-01), Villalobos et al.
patent: 5756754 (1998-05-01), O'Malley et al.
patent: 5780475 (1998-07-01), Baker et al.
patent: 5854247 (1998-12-01), Baker et al.
patent: 5925766 (1999-07-01), O'Malley et al.
patent: 5965582 (1999-10-01), Lebaut et al.
patent: 5973156 (1999-10-01), Chambers et al.
patent: 5977116 (1999-11-01), Castro Pineiro et al.
patent: 5998415 (1999-12-01), Chambers et al.
patent: 6046203 (2000-04-01), O'Malley et al.
patent: 6054456 (2000-04-01), Ladduwahetty et al.
patent: 6166023 (2000-12-01), Schindler et al.
patent: 6166027 (2000-12-01), Straub et al.
patent: 6326382 (2001-12-01), Villalobos et al.
patent: 6329412 (2001-12-01), Goldstein et al.
patent: 6387940 (2002-05-01), Straub et al.
patent: 6391872 (2002-05-01), Marfat
patent: 6410740 (2002-06-01), Straub et al.
patent: 6414009 (2002-07-01), Straub et al.
patent: 6451805 (2002-09-01), Straub et al.
patent: 6462068 (2002-10-01), Straub et al.
patent: 6465467 (2002-10-01), Nilsson et al.
patent: 6498255 (2002-12-01), Villalobos et al.
patent: 6541484 (2003-04-01), Collins et al.
patent: 6552192 (2003-04-01), Hanus et al.
patent: 6743798 (2004-06-01), Straub et al.
patent: 2002/0028834 (2002-03-01), Villalobos et al.
patent: 2002/0052373 (2002-05-01), Zorn et al.
patent: 2002/0198213 (2002-12-01), Zhou et al.
patent: 2003/0073849 (2003-04-01), Mattson et al.
patent: 2003/0092694 (2003-05-01), Nilsson et al.
patent: 2003/0176421 (2003-09-01), Watson et al.
patent: 2003/0191086 (2003-10-01), Hanus et al.
patent: 2004/0034101 (2004-02-01), Rao et al.
patent: 2004/0063713 (2004-04-01), Cowart et al.
patent: 2004/0186148 (2004-09-01), Shankar et al.
patent: 2004/0224945 (2004-11-01), Straub et al.
patent: 2004/0236101 (2004-11-01), Makriyannis et al.
patent: 2004/0242554 (2004-12-01), Nilsson et al.
patent: 2006/0019967 (2006-01-01), Wu et al.
patent: 3338903 (1985-05-01), None
patent: 33 38 903 (1993-03-01), None
patent: 0 135 781 (1989-10-01), None
patent: 0582832 (1993-03-01), None
patent: 1 040 829 (1999-12-01), None
patent: 2 034 495 (1970-01-01), None
patent: 2034495 (1970-01-01), None
patent: 58-159469 (1983-09-01), None
patent: 3-223265 (1991-10-01), None
patent: 11-279156 (1999-10-01), None
patent: 2003-146879 (2003-05-01), None
patent: 2003-146973 (2003-05-01), None
patent: WO 98/01428 (1998-01-01), None
patent: WO 99/58503 (1999-11-01), None
patent: WO 00/06559 (2000-02-01), None
patent: WO00/06569 (2000-02-01), None
patent: WO 00/27394 (2000-05-01), None
patent: WO 01/44244 (2001-06-01), None
patent: WO01/44244 (2001-06-01), None
patent: WO 01/57024 (2001-08-01), None
patent: WO 01/70701 (2001-09-01), None
patent: WO 01/70702 (2001-09-01), None
patent: WO 03/076408 (2003-09-01), None
patent: WO 03/101994 (2003-12-01), None
Baiocchi, et al, Synthesis, Properties, and Reactions of 1H-Indazol-3-ols and 1,2-Dihydro-3H-indazol-3-ones, Synthesis, Sep. 1978, 633-648.
Palazzo, et al, Synthesis and Pharmacological Properties of 1-Substituted 3-Dimethylaminoalkoxy-1H-indazoles, J. Med. Chem., Jan. 1966, vol. 9, 38-41.
Selwood, et al, Synthesis and Biological Evaluation of Novel Pyrazoles and Indazoles as Activators of the Nitric Oxide Receptor, soluble Guanylate Cyclase, J. Med. Chem., 2001, vol. 4, 78-93.
Sluka, Stimulation of Deep Somatic Tissue with Capsacin Produces Long-Lasting Mechanical Allodynia and Heat Hypoalgesia that Depends on Early Activation of the cAMP Pathway, J. Neurosci., Jul. 2002, vol. 22, 5687-5693.
PCT international Search Report for PCT/IB2005/003549 mailed Oct. 19, 2006.
Eck Steven R.
Rahmani Niloofar
Seaman D. Margaret
Warner Lambert Company LLC
LandOfFree
Therapeutic pyrazolo[3,4-b]pyridines and indazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic pyrazolo[3,4-b]pyridines and indazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic pyrazolo[3,4-b]pyridines and indazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3983431